Richard Buick

431 total citations
12 papers, 341 citations indexed

About

Richard Buick is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Richard Buick has authored 12 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Richard Buick's work include interferon and immune responses (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Richard Buick is often cited by papers focused on interferon and immune responses (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Richard Buick collaborates with scholars based in United Kingdom, Italy and Ireland. Richard Buick's co-authors include James F. Burrows, Caroline R. Boyd, Joanne Elliott, James A. Johnston, Christopher J. Scott, Ping Qian, Ultan F. Power, Oonagh T. Lynch, Olivier Touzelet and Massimo Gadina and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Richard Buick

12 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Buick United Kingdom	8	146	127	125	68	64	12	341
Dawn Jaquish United States	8	93 0.6×	131 1.0×	73 0.6×	29 0.4×	123 1.9×	9	380
Isis Torréns Cuba	11	147 1.0×	225 1.8×	63 0.5×	20 0.3×	45 0.7×	21	377
Daniel J. Verdon New Zealand	11	164 1.1×	103 0.8×	196 1.6×	53 0.8×	140 2.2×	15	473
Melissa E. Laird France	8	157 1.1×	116 0.9×	97 0.8×	98 1.4×	222 3.5×	10	482
Raquel P. Deering United States	9	222 1.5×	305 2.4×	48 0.4×	55 0.8×	94 1.5×	16	532
Viraj Mane United States	12	156 1.1×	362 2.9×	93 0.7×	120 1.8×	99 1.5×	15	672
Takahiro Ohtsuki Japan	11	85 0.6×	157 1.2×	91 0.7×	51 0.8×	30 0.5×	18	372
Claire Lastrucci France	12	272 1.9×	192 1.5×	104 0.8×	129 1.9×	62 1.0×	12	523
Kazuyo Gotoh Japan	11	145 1.0×	168 1.3×	42 0.3×	100 1.5×	138 2.2×	12	446
Deepyan Chatterjee India	9	273 1.9×	126 1.0×	43 0.3×	44 0.6×	68 1.1×	11	428

Countries citing papers authored by Richard Buick

Since Specialization

Citations

This map shows the geographic impact of Richard Buick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Buick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Buick more than expected).

Fields of papers citing papers by Richard Buick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Buick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Buick. The network helps show where Richard Buick may publish in the future.

Co-authorship network of co-authors of Richard Buick

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Buick. A scholar is included among the top collaborators of Richard Buick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Buick. Richard Buick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Buick, Richard, et al.. (2021). Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(1). 188557–188557. 7 indexed citations

Graham, Rondell P., Nathan W. Cummins, Enrique Garcia-Rivera, et al.. (2020). Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells. Clinical Cancer Research. 26(21). 5759–5771. 5 indexed citations

Vázquez, Ramiro, Lucile Astorgues‐Xerri, Mohamed Békradda, et al.. (2014). Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors. Biochimie. 108. 101–107. 15 indexed citations

Camper, N. D., Roberta E. Burden, James A. Johnston, et al.. (2011). Stable expression and purification of a functional processed Fab′ fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptor. Journal of Immunological Methods. 372(1-2). 30–41. 6 indexed citations

Buick, Richard, et al.. (2010). Magnetizable antibody‐like proteins. Biotechnology Journal. 5(6). 596–604. 11 indexed citations

Kwok, Hang Fai, et al.. (2010). Expression and purification of diagnostically sensitive mycobacterial (Mycobacterium bovis) antigens and profiling of their humoral immune response in a rabbit model. Research in Veterinary Science. 89(1). 41–47. 4 indexed citations

Buick, Richard, et al.. (2009). Production of recombinant proteins in Escherichia coli using an N-terminal tag derived from sortase. Protein Expression and Purification. 70(2). 143–150. 11 indexed citations

Funaro, Ada, Giorgio Gribaudo, Anna Luganini, et al.. (2008). Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. BMC Biotechnology. 8(1). 85–85. 16 indexed citations

Burden, Roberta E., et al.. (2008). Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L–like proteases in tumor microenvironment. Molecular Cancer Therapeutics. 7(3). 538–547. 26 indexed citations

10.

Scott, Christopher J., Derek J. Quinn, Richard Buick, et al.. (2007). Immunocolloidal Targeting of the Endocytotic Siglec-7 Receptor Using Peripheral Attachment of Siglec-7 Antibodies to Poly(Lactide-co-Glycolide) Nanoparticles. Pharmaceutical Research. 25(1). 135–146. 35 indexed citations

11.

Elliott, Joanne, Oonagh T. Lynch, Yvonne Suessmuth, et al.. (2007). Respiratory Syncytial Virus NS1 Protein Degrades STAT2 by Using the Elongin-Cullin E3 Ligase. Journal of Virology. 81(7). 3428–3436. 154 indexed citations

12.

Orr, Selinda J., Richard Buick, Caroline R. Boyd, et al.. (2006). SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated Responses. Journal of Biological Chemistry. 282(6). 3418–3422. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact